[Problems of and strategies in nucleotide analogues therapy for chronic hepatitis B].
Hou
Jin-lin
JL
Department of Infectious Diseases, Nanfang Hospital, Nanfang University of Medical Sciences, Guangzhou 510510, China. jlhou@fimmu.com
Zeng
Guo-bing
GB
D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D009705:Nucleosides / Q000627:therapeutic use*; D063065:Organophosphonates / Q000627:therapeutic use
D009705:Nucleosides; D063065:Organophosphonates; D019259:Lamivudine; C413685:entecavir; D006147:Guanine; D000225:Adenine; C106812:adefovir dipivoxil